Universal screening of pregnant women is feasible and has led to immunisation in nearly all identified cases in Denmark. As a consequence of the study the National Board of Health has made universal HBsAg screening of pregnant women permanent in the country.
Similar to other European countries, cervical infection with HPV-16, the HPV type with the strongest oncogenic potential, were most common both overall and among women with cervical disease.
The meeting brought together researchers, microbiologists and public health experts to discuss how public health can benefit from the recent scientific and technological advances in molecular microbiology, with special focus on the rapidly evolving next generation sequencing technology.
The objective of this expert consultation was to guide, harmonize and enhance the surveillance and prevention of tick-borne diseases in EU Member States, with special emphasis on Lyme borreliosis and tick-borne encephalitis.
On the 22 November 2011, ECDC organised a workshop at the European Parliament to provide policy makers with more information on the facts about seasonal influenza vaccination and on ECDC’s contributions to the implementation of the 2009 Council Recommendation on this subject.
ECDC publishes weekly West Nile fever maps, based on information provided by the health authorities across Europe, with the objective to inform the national competent authorities about WNV affected areas.
According to the available epidemiological and entomological information, and the arriving winter season, the intensity of malaria transmission in Evrotas, Lakonia in Greece is very low.
On the occasion of the fourth annual European Antibiotic Awareness Day (EAAD), ECDC is releasing new European-wide surveillance data showing that the percentage of carbapenem-resistant Klebsiella pneumoniae is increasing the European Union. Several Member States are now reporting that between 15 percent and almost 50 percent of K. pneumoniae from bloodstream infections are resistant to carbapenems. Carbapenems are the major last-line class of antibiotics to treat infections with multidrug-resistant Gram-negative bacteria such as Klebsiella pneumoniae, a frequent cause of pneumonia and urinary tract infections in hospitals.